SecBot SecBot
Insider Cluster (3 insiders) ·Filed Jun 17, 2026

NTRA

Natera, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed5mo ago
Insider cluster: 2 insiders, $542K total
Actionable Insight • Neutral

No material signal from this insider cluster. The dollar amounts are negligible relative to market cap, and insider sells are generally less informative than buys. Monitor for any upcoming earnings or material events that might prompt larger insider activity.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$231.41
T+0 close · Jun 17, 2026 · via day close
Latest settled
+47.70%
T+60 · $341.79
Vs SPY
+45.81%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 18 $231.41entry
  2. T+1 · 5mo ago −1.13%α −0.81% · $228.80
  3. T+5 · 5mo ago +12.67%α +14.34% · $260.74
  4. T+20 · 4mo ago +16.60%α +16.07% · $269.83
  5. T+60 · 2mo ago +47.70%α +45.81% · $341.79
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Three NTRA insiders (Executive Chairman and two directors) sold a total of ~$1.72M in open-market sales over a 7-day window. The dollar amount represents less than 0.01% of the company's $31.5B market cap, making this a routine and immaterial cluster.

Key Financial Metrics

Direction
selling
Total Value
$1.7M
Insiders
3

Key Facts

  • Total insider sales of $1.72M over 7 days (4 trades)
  • Executive Chairman Matthew Rabinowitz sold $705,652 across two trades
  • Directors Jonathan Sheena and Rowan Chapman sold $368,011 and $642,536 respectively
  • Sales represent ~0.0055% of NTRA's $31.5B market cap
  • All transactions were open-market sells; no 10b5-1 plan indicated

Financial Impact

Insider sales of $1.72M, trivial relative to $31.5B market cap

dilution

Risk Factors

  • Insider selling pattern could accelerate if fundamentals deteriorate
  • Low trading volume could amplify price impact of future sales

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories
Analyst Consensus
89% bullish (27 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NTRA-1781744738215

Track record

63 reports on NTRA

Performance horizon

6 of 9 bullish or bearish reports moved the stock their way by T+1. Best: +6.55% at T+5 after the Oct 2, 2026 report. 6 of 9 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $300.44 Now $319.09 +6.21% settles Nov 17
  2. Nov 10, 20266d ago Insider Cluster Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
  3. Nov 10, 20266d ago S-3ASR Neutral 3/10 Entry $319.82 to $322.94 Now $319.09 −0.23% ▲ +0.98% +1.33% vs SPY
  4. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
  5. Nov 5, 202611d ago 8-K Mixed 6/10 Entry $310.67 to $320.39 Now $319.09 +2.71% ▲ +3.13% +0.76% vs SPY
  6. Nov 5, 202611d ago SC 13G Neutral 4/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
  7. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $363.76 to $310.67 Now $319.09 −12.28% ▼ −14.59% −14.91% vs SPY
  8. Nov 3, 202613d ago 144 Neutral 2/10 Entry $391.03 to $363.76 Now $319.09 −18.40% ▼ −6.97% −2.56% vs SPY
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
  10. Nov 2, 202614d ago 144 Neutral 3/10 Entry $388.63 to $391.03 Now $319.09 −17.89% ▲ +0.62% −1.03% vs SPY
Showing 10 of 63

US Market Status

Market Closed · Opens Wed (11h 55m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 17, 2026